NPI: 1982822631 · JACKSONVILLE, AR 72076 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/20/2007
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/20/2007 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,726 | $106K |
| 2019 | 14,753 | $142K |
| 2020 | 15,396 | $141K |
| 2021 | 8,913 | $82K |
| 2022 | 11,076 | $126K |
| 2023 | 7,525 | $93K |
| 2024 | 1,530 | $23K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 83970 | 1,148 | 1,034 | $143K | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 30,749 | 1,891 | $143K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 19,092 | 1,453 | $132K |
| 82728 | 683 | 617 | $74K | |
| 82108 | 188 | 171 | $52K | |
| A4657 | Syringe, with or without needle, each | 1,533 | 1,312 | $50K |
| 83540 | 742 | 668 | $26K | |
| 83550 | 652 | 582 | $24K | |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,072 | 742 | $18K |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,117 | 891 | $17K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 318 | 159 | $17K |
| 85041 | 1,390 | 1,229 | $8K | |
| 85048 | 1,361 | 1,207 | $6K | |
| J1756 | Injection, iron sucrose, 1 mg | 3,686 | 978 | $2K |
| 82746 | 52 | 48 | $2K | |
| 85045 | 109 | 95 | $0.00 | |
| 90674 | 27 | 25 | $0.00 |